Hims & Hers Health, Inc.(HIMS)

Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products, primarily focusing on wellness, sexual health and wellness, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, biotin, and collagen protein supplements in the wellness category; moisturizer, serums, and face wash in the skincare category; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. In addition, it offers medical consultation services, as well as health and wellness products through wholesale partners. The company is based in San Francisco, California.
Latest News & Analysis
Hims & Hers Health Inc. Latest Legal Challenges and Financial Analysis - Monexa AI
Explore Hims & Hers Health's recent legal challenges, partnership termination, and robust financial growth with detailed market and financial analysis.
Hims & Hers Health, Inc. (HIMS) Faces Securities Fraud Lawsuit Amid Market Volatility
Hims & Hers Health, Inc. (HIMS) confronts securities fraud allegations linked to deceptive marketing, triggering sharp stock declines and investor lawsuits.
Hims & Hers Health, Inc. (HIMS) Legal Challenges and Financial Resilience: A Data-Driven Analysis
Explore how Hims & Hers Health, Inc. (HIMS) navigates securities fraud allegations amid strong revenue growth and improving profitability.
Hims & Hers Health, Inc. (HIMS) Lawsuit Impact and Financial Analysis - Monexa AI
Hims & Hers Health faces securities fraud lawsuit with significant stock volatility and financial shifts; detailed analysis of recent developments and future outlook.
Hims & Hers Health Inc. (HIMS) Faces Legal Turbulence Amid Novo Nordisk Split and Market Volatility
Hims & Hers Health (HIMS) confronts securities fraud allegations after Novo Nordisk partnership ends, causing sharp stock drop and investor scrutiny.
Hims & Hers Health (HIMS) Faces Legal Turbulence Amid Novo Nordisk Fallout and Strategic Shifts
Hims & Hers Health stock surges +4.66% post legal setbacks tied to Novo Nordisk partnership dispute, revealing key financial impacts and strategic pivots in 2025.
Hims & Hers Health, Inc. Latest Corporate Developments and Financial Analysis
In-depth analysis of Hims & Hers Health's recent legal challenges, partnership termination, and financial performance revealing strategic and market impacts.
Hims & Hers Health, Inc. Legal Challenges and Financial Performance Analysis
Hims & Hers faces securities fraud allegations and partnership termination with Novo Nordisk, impacting its stock and financial fundamentals.
Hims & Hers Health, Inc. (HIMS) Latest Legal Challenges and Financial Performance Analysis
Explore Hims & Hers Health, Inc.'s recent securities fraud lawsuit, partnership termination, and financial growth insights impacting investor decisions.
Hims & Hers Health, Inc. (HIMS) Latest Financial and Strategic Update
Explore Hims & Hers Health's recent financial performance, strategic moves, and market positioning with data-driven insights for investors.
Hims & Hers Health, Inc. Market Update: Strategic Positioning and Financial Insights
Hims & Hers Health, Inc. shows strategic momentum with solid stock performance and evolving market positioning as of June 2025.
Hims & Hers (HIMS): Weight-Loss Strategy, Competition, and Risks
Hims & Hers Health, Inc. navigates telehealth competition, expands weight-loss offerings, and faces regulatory risks. A comprehensive analysis of HIMS's strategic moves and market dynamics.
Hims & Hers Health, Inc.: Adapting to Market Shifts and Diversifying Growth
Hims & Hers faces market shifts due to GLP-1 drug availability. Strategic acquisitions and diversification are key to navigating the evolving landscape.
Hims & Hers Stock Surge: Growth Drivers and Market Outlook
Latest analysis reveals Hims & Hers's robust growth, strategic marketing, and expansion fueling its stock surge amid a competitive telehealth market.